Received Feb 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 34MF9 | — |
Expired dose/ Expiration date was 13 February 2026, and the vaccine was administrated on 16 February 2026; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number 34MF9, expiry date 13-FEB-2026) for prophylaxis. On 16-FEB-2026, the patient received the 1st dose of Kinrix. On 16-FEB-2026, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired dose/ Expiration date was 13 February 2026, and the vaccine was administrated on 16 February 2026). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-FEB-2026 A clinic manager called to get guidance and know how to proceed after an expired dose of Kinrix was administrated. The vaccine administration facility was the same as primary reporter.